Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB- but not chemically induced non-melanoma skin cancer
Scientific Reports
2023
13
1
Pathways linking aging and atheroprotection in
Mif
‐deficient atherosclerotic mice
The FASEB Journal
2023
37
3
Lasso-grafted designer cytokines
Nature Biomedical Engineering
2022
Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation
Cellular and Molecular Life Sciences
2022
79
10
Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly
Nature Communications
2022
13
1
Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting
Nature Communications
2020
11
1
A MIF‐derived cyclopeptide that inhibits MIF binding and atherogenic signaling via the chemokine receptor CXCR2
ChemBioChem
2020
Enlightening amyloid fibrils linked to type 2 diabetes and cross-interactions with Aβ
Nature Structural & Molecular Biology
2020
27
11
1006-1008
Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements
Angewandte Chemie International Edition
2018
57
44
14503-14508
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation
Thrombosis and Haemostasis
2019
119
04
553-566